{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:49:26Z","timestamp":1791355766277,"version":"4.3.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with congestive heart failure (CHF) and type 2 diabetes mellitus (T2DM) are at elevated risk of in-hospital mortality, particularly in intensive care units (ICUs). Conventional scoring systems may not fully capture the clinical complexity of such comorbidities. This study aimed to construct an interpretable machine learning model to predict in-hospital mortality in this high-risk group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study included 573 ICU patients with CHF and T2DM admitted to three hospitals in Henan, China (Jan 2025\u2013Jun 2026). Seven predictors\u2014body mass index (BMI), myocardial infarction, mild liver disease, SOFA score, LODS score, white blood cell (WBC) count, and serum creatinine\u2014were identified via stepwise logistic regression. XGBoost and four other machine learning algorithms (KNN, SVM, CatBoost, AdaBoost) were trained and evaluated. Model performance was assessed using AUC, accuracy, sensitivity, specificity, and F1-score. SHAP (SHapley Additive exPlanations) was used to interpret XGBoost predictions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>XGBoost achieved the best performance (AUC 0.917, sensitivity 86.8%, specificity 96.6%, accuracy 74.8%). SHAP analysis indicated that mild liver disease, LODS score, BMI, WBC count, and SOFA score were the top contributors, jointly explaining over 77% of the predictive power. Myocardial infarction, liver disease, elevated WBC, and higher SOFA\/LODS scores increased mortality risk, while higher BMI and serum creatinine were protective\u2014supporting the obesity paradox and sarcopenia hypothesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>An XGBoost model with SHAP interpretation provides accurate, explainable prediction of in-hospital mortality in ICU patients with CHF and T2DM, offering a valuable tool for early risk stratification and clinical decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1951635","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:50:12Z","timestamp":1791352212000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A machine learning\u2013driven and explainable prediction model for in-hospital mortality in patients with diabetes mellitus and congestive heart failure: integrating XGBoost and SHAP approaches"],"prefix":"10.3389","volume":"14","author":[{"given":"Jingru","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Acupuncture and Massage, The Third People\u2019s Hospital of Henan Province","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiong","family":"Su","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, The Third People\u2019s Hospital of Henan Province","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Surgery, The Third People\u2019s Hospital of Henan Province","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.15420\/cfr.2023.05","article-title":"Global public health burden of heart failure: an updated review","volume":"9","author":"Shahim","year":"2023","journal-title":"Card Fail Rev"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke Statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40779-025-00615-1","article-title":"The national and provincial prevalence and non-fatal burdens of diabetes in China from 2005 to 2023 with projections of prevalence to 2050","volume":"12","author":"Zhou","year":"2025","journal-title":"Mil Med Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.31083\/j.rcm2512436","article-title":"Diabetes mellitus and cardiovascular disease: exploring epidemiology, pathophysiology, and treatment strategies","volume":"25","author":"Siam","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12933-024-02136-y","article-title":"The double burden: type 1 diabetes and heart failure\u2014a comprehensive review","volume":"23","author":"Juli\u00e1n","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s00125-023-06068-2","article-title":"Epidemiology of heart failure in diabetes: a disease in disguise","volume":"67","author":"Hoek","year":"2024","journal-title":"Diabetologia"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.15062","article-title":"Heart failure and diabetes: clinical significance and epidemiology of this two-way association","volume":"25","author":"Jerkins","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10741-022-10238-6","article-title":"Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence","volume":"28","author":"Palazzuoli","year":"2023","journal-title":"Heart Fail Rev"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1093\/jamia\/ocac098","article-title":"Development and validation of a deep learning model to predict the survival of patients in ICU","volume":"29","author":"Tang","year":"2022","journal-title":"J Am Med Inform Assoc"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3233\/SHTI250380","article-title":"XGBOrdinal: an XGBoost extension for ordinal data","volume":"327","author":"Kahl","year":"2025","journal-title":"Stud Health Technol Inform"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10916-020-01701-8","article-title":"Shedding light on the black box: explaining deep neural network prediction of clinical outcomes","volume":"45","author":"Shao","year":"2021","journal-title":"J Med Syst"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e70056","DOI":"10.1111\/cts.70056","article-title":"Practical guide to SHAP analysis: explaining supervised machine learning model predictions in drug development","volume":"17","author":"Ponce-Bobadilla","year":"2024","journal-title":"Clin Transl Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/dc25-S002","article-title":"Diagnosis and classification of diabetes: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/ejhf.2495","article-title":"Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK biobank","volume":"24","author":"Rastogi","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.3390\/ijms25052610","article-title":"Behavior of hypertrophied right ventricle during the development of left ventricular failure due to myocardial infarction","volume":"25","author":"Dhalla","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pcad.2024.01.017","article-title":"The spectrum of post-myocardial infarction care: from acute ischemia to heart failure","volume":"82","author":"Akhtar","year":"2024","journal-title":"Prog Cardiovasc Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/ejhf.2961","article-title":"Heart failure after myocardial infarction: glass emptier than full","volume":"25","author":"Harrington","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.jchf.2024.04.025","article-title":"Where are we with treatment and prevention of heart failure in patients post-myocardial infarction?","volume":"12","author":"Carberry","year":"2024","journal-title":"JACC Heart Fail"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1177\/2047487320904232","article-title":"Diabetes and heart failure post-acute myocardial infarction: important associations and need for evidence-based interventions","volume":"27","author":"Parizo","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijcard.2021.11.086","article-title":"Influence of diabetes mellitus interactions with cardiovascular risk factors on post-myocardial infarction heart failure hospitalizations","volume":"348","author":"Yandrapalli","year":"2022","journal-title":"Int J Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1136\/gutjnl-2021-325724","article-title":"Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort","volume":"71","author":"Simon","year":"2022","journal-title":"Gut"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J Diabetes Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e076388","DOI":"10.1136\/bmj-2023-076388","article-title":"Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study","volume":"384","author":"Kim","year":"2024","journal-title":"BMJ"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/ejhf.1378","article-title":"Multi-organ dysfunction\/injury on admission identifies acute heart failure patients at high risk of poor outcome","volume":"21","author":"Zymli\u0144ski","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13054-022-04290-9","article-title":"The sequential organ failure assessment (SOFA) score: has the time come for an update?","volume":"27","author":"Moreno","year":"2023","journal-title":"Crit Care"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1542\/peds.2021-052888D","article-title":"Scoring systems for organ dysfunction and multiple organ dysfunction: the PODIUM consensus conference","volume":"149","author":"Schlapbach","year":"2022","journal-title":"Pediatrics"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.18087\/cardio.2024.7.n2562","article-title":"Inflammatory biomarkers in patients with type 2 diabetes mellitus and heart failure with preserved ejection faction","volume":"64","author":"Sveklina","year":"2024","journal-title":"Kardiologiia"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jare.2022.01.014","article-title":"DNA-PKcs promotes sepsis-induced multiple organ failure by triggering mitochondrial dysfunction","volume":"41","author":"Zou","year":"2022","journal-title":"J Adv Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.pcad.2022.11.013","article-title":"Updates on obesity and the obesity paradox in cardiovascular diseases","volume":"78","author":"Tutor","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13054-022-04148-0","article-title":"Obesity and critical care nutrition: current practice gaps and directions for future research","volume":"26","author":"Dickerson","year":"2022","journal-title":"Crit Care"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/jdi.13003","article-title":"Lower body mass index is not of more benefit for diabetic complications","volume":"10","author":"Zhang","year":"2019","journal-title":"J Diabetes Investig"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3390\/nu17040732","article-title":"Nutrition therapy in critically ill patients with obesity: an observational study","volume":"17","author":"Lopez-Delgado","year":"2025","journal-title":"Nutrients"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.3390\/jcm13072086","article-title":"BMI-stratified exploration of the 'obesity paradox': heart failure perspectives from a large German insurance database","volume":"13","author":"Hobbach","year":"2024","journal-title":"J Clin Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.2147\/DMSO.S491681","article-title":"BMI and mortality: the diabetes-obesity paradox examined in a large US cohort","volume":"18","author":"Conway","year":"2025","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"592","DOI":"10.26355\/eurrev_202301_31060","article-title":"Prognostic significance of low basal serum creatinine levels in internal intensive care unit patients","volume":"27","author":"Sahin Tutak","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2147\/TCRM.S464722","article-title":"Risk factors and Electromyographic characteristics of acquired weakness in critically ill patients: a retrospective study","volume":"20","author":"Li","year":"2024","journal-title":"Ther Clin Risk Manag"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cvdhj.2023.06.001","article-title":"Explainable SHAP-XGBoost models for in-hospital mortality after myocardial infarction","volume":"4","author":"Tarabanis","year":"2023","journal-title":"Cardiovasc Digit Health J"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1951635\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:50:13Z","timestamp":1791352213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1951635\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":41,"alternative-id":["10.3389\/fpubh.2026.1951635"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1951635","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"1951635"}}